Drug
AZ 3102
AZ 3102: highest development phase Phase 2, developed by Azafaros B.V.. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Azafaros B.V.
Trials
| Drug | Phase | Indication |
|---|---|---|
| AZ-3102 NCT07715084 | Phase 2 | Gaucher Disease Type 3 |
Latest
No recent events.
Follow AZ 3102 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.